Cargando…

Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

BACKGROUND: Randomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of LDL cholesterol are associated with increased susc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freyberg, Josefine, Landt, Eskild M., Afzal, Shoaib, Nordestgaard, Børge G., Dahl, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986766/ https://www.ncbi.nlm.nih.gov/pubmed/36891075 http://dx.doi.org/10.1183/23120541.00496-2022

Ejemplares similares

The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30 824 Europeans: the Copenhagen General Population Study
por: Mortensen, Martin B., et al.
Publicado: (2015)

Second-Hand Smoke Exposure Associated with Risk of Respiratory Symptoms, Asthma, and COPD in 20,421 Adults from the General Population
por: Korsbæk, Nanna, et al.
Publicado: (2021)

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

Causal risk factors for asthma in Mendelian randomization studies: A systematic review and meta‐analysis
por: Mikkelsen, Heidi, et al.
Publicado: (2022)

α(1)-Antitrypsin deficiency associated with increased risk of heart failure
por: Winther, Sine V., et al.
Publicado: (2023)

Venous thromboembolism associated with severe dyspnoea and asthma in 102 792 adults
por: Nilausen, Kristin Felicia, et al.
Publicado: (2023)

Severe α(1)-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis
por: Winther, Sine Voss, et al.
Publicado: (2022)

Markers of early disease and prognosis in COPD
por: Dahl, Morten, et al.
Publicado: (2009)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
por: Doi, Takahito, et al.
Publicado: (2023)

Supernormal lung function and risk of COPD: A contemporary population-based cohort study
por: Çolak, Yunus, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults
por: Holtermann, Andreas, et al.
Publicado: (2021)

Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
por: Dahl, Morten, et al.
Publicado: (2005)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals
por: Bækvad-Hansen, Marie, et al.
Publicado: (2012)

Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population
por: Shi, Liu, et al.
Publicado: (2023)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
por: Bruckert, Eric, et al.
Publicado: (2020)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Validation of low-density lipoprotein cholesterol equations in pediatric population
por: Ertürk Zararsız, Gözde, et al.
Publicado: (2023)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population
por: Zhou, Dan, et al.
Publicado: (2022)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Visit-to-visit variability in low-density lipoprotein cholesterol
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion
por: Dannecker, Corinna, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study
por: Wang, Xiao-rong, et al.
Publicado: (2018)

Correlation of Friedewald's calculated low-density lipoprotein cholesterol levels with direct low-density lipoprotein cholesterol levels in a tertiary care hospital
por: Nanda, Sunil Kumar, et al.
Publicado: (2017)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals
por: Pedersen, Kasper Mønsted, et al.
Publicado: (2020)

High-density lipoprotein revisited: biological functions and clinical relevance
por: von Eckardstein, Arnold, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j86q9i6l2087675lns1dreo0t9